All4NutraNo products in the cart.
All4NutraStartseite » News » Page 96
Abstract Inflammatory bowel disease (IBD) comprises chronic autoimmune disorders with significant morbidity, highlighting the need for advanced, noninvasive, targeted therapies....
Abstract Ketoconazole (KTZ) functions by suppressing the propagation of ergosterol, an essential element of the fungal cell membrane. However, its...
Abstract This study investigates the solubility and miscibility of ibuprofen (IBU) with four pharmaceutical polymers, KOLVA64®, KOL17PF®, HPMCAS, and Eudragit®...
Abstract Psoriasis is a hereditary, autoimmune, chronic illness that influences the immune system and can have both cutaneous and systemic...
Abstract Pharmacological treatment of epilepsy is challenged by several barriers with the blood brain barrier (BBB) imposing the utmost restrictions...
Abstract NNitrosamine risk assessment and control are essential components of pharmaceutical drug development and product evaluation. Nitrites present in excipients...
BASF has news for drug formulators! They introduced a new ‘Nitrosamine Risk Assessment and Mitigation’ app in ZoomLab®, their Virtual...
What are the most popular excipients in 2024 and what has changed in the last 20 years? The numbers say:...
Abstract Traditional extemporaneous compounding methods of solid oral dosage forms required in early-stage studies are laborious, and the drug’s solid...
Sustainability in the Manufacturing of Pharmaceuticals See the new book, edited by Dimitrios A. Lamprou. This book compiles cutting-edge research from...
Copyright: PharmaExcipients AG